Statins for EBV-lymphoma
Author Information
Author(s): Cohen J I
Primary Institution: National Institute of Allergy and Infectious Diseases, National Institutes of Health
Hypothesis
Can statins be used to treat Epstein–Barr virus-driven lymphoma?
Conclusion
Statins may help treat EBV-driven lymphomas by inducing apoptosis in transformed B cells.
Supporting Evidence
- Simvastatin induces apoptosis in EBV-positive Burkitt lymphoma cells.
- Statins inhibit NF-κB activation in EBV-transformed B cells.
- Simvastatin delays the development of EBV-lymphomas in SCID mice.
Takeaway
Statins, which are usually used to lower cholesterol, might also help fight certain types of cancer caused by a virus called EBV.
Methodology
The study involved treating EBV-transformed B cells with simvastatin and observing the effects on cell death and lymphoma development in SCID mice.
Limitations
The study primarily focused on animal models, and the doses of statins used were much higher than those typically prescribed for cholesterol management.
Statistical Information
P-Value
p<0.04
Statistical Significance
p<0.04
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website